醋酸烯諾孕酮/乙炔雌二醇

醋酸烯諾孕酮/乙炔雌二醇
	乙炔雌二醇（上方） ; 醋酸烯諾孕酮（下方）
組成
醋酸烯諾孕酮	孕酮
乙炔雌二醇	雌激素
臨床資料
商品名（英語：Drug nomenclature）	Annovera
其他名稱	EE/SGA; EE/SA
AHFS/Drugs.com	專業藥物信息
MedlinePlus	a604032
核准狀況	美 DailyMed: Segesterone_acetate_and_ethinyl_estradiol;
給藥途徑	陰道內給藥
ATC碼	未分配;
法律規範狀態
法律規範	美：處方藥（℞-only）;
識別資訊
KEGG	D11654;

醋酸烯諾孕酮/乙炔雌二醇（EE/SGA），品牌藥名稱為Annovera，是一種陰道避孕環，使用復方激素避孕，成分包含醋酸烯諾孕酮、孕激素、炔雌醇及雌激素。^[1]^[2]^[3]當中炔雌醇含量為17.4毫克，醋酸烯諾孕酮為103毫克，平均每天會釋放出13微克炔雌醇及0.15毫克醋酸烯諾孕酮。^[1]^[4]

Annovera需插入並放置在陰道21天，然後取出清洗並存放7天，在此期間使用者會有經期（撤出性出血），重複13次，共使用一年。^[5]Annovera與陰道避孕藥環NuvaRing不同，Annovera使用前不需冷藏，可儲存在高達30攝氏度的環境。^[1]

此藥物由國際非牟利組織人口委員會開發，授權TherapeuticsMD製造。2018年8月，美國批准使用此藥物作醫療用途。^[4]^[6]

參見

參考文獻

^ ^1.0 ^1.1 ^1.2 ^1.3 Annovera- segesterone acetate and ethinyl estradiol ring. DailyMed. 7 August 2020 [10 October 2020]. （原始內容存檔於2021-03-29）. "Annovera- segesterone acetate and ethinyl estradiol ring" （頁面存檔備份，存於網際網路檔案館）. DailyMed. 7 August 2020. Retrieved 10 October 2020.
^ Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method. Expert Review of Clinical Pharmacology. October 2019, 12 (10): 953–963. PMID 31526281. doi:10.1080/17512433.2019.1669448.
^ Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. American Family Physician. May 2020, 101 (10): 618–620. PMID 32412221.
^ ^4.0 ^4.1 TherapeuticsMD Inc (新聞稿). 缺少或|title=為空 (幫助)
^ U.S. Food and Drug Administration (FDS) (新聞稿). 缺少或|title=為空 (幫助)
^ Drug Approval Package: Annovera (segesterone acetate and ethinyl estradiol). U.S. Food and Drug Administration (FDA). 10 September 2018 [10 October 2020]. （原始內容存檔於2022-03-23）.

外部連結

Segesterone acetate. Drug Information Portal. U.S. National Library of Medicine.
Ethinylestradiol. Drug Information Portal. U.S. National Library of Medicine. [2022-03-23]. （原始內容存檔於2021-04-21）.

[Annovera_FDA_label-1] 1.0 ^1.1 ^1.2 ^1.3 Annovera- segesterone acetate and ethinyl estradiol ring. DailyMed. 7 August 2020 [10 October 2020]. （原始內容存檔於2021-03-29）. "Annovera- segesterone acetate and ethinyl estradiol ring" （頁面存檔備份，存於網際網路檔案館）. DailyMed. 7 August 2020. Retrieved 10 October 2020.

[Nelson_2019-2] Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method. Expert Review of Clinical Pharmacology. October 2019, 12 (10): 953–963. PMID 31526281. doi:10.1080/17512433.2019.1669448.

[Lee_2020-3] Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. American Family Physician. May 2020, 101 (10): 618–620. PMID 32412221.

[TherapeuticsMD2018-4] 4.0 ^4.1 TherapeuticsMD Inc (新聞稿). 缺少或|title=為空 (幫助)

[5] U.S. Food and Drug Administration (FDS) (新聞稿). 缺少或|title=為空 (幫助)

[6] Drug Approval Package: Annovera (segesterone acetate and ethinyl estradiol). U.S. Food and Drug Administration (FDA). 10 September 2018 [10 October 2020]. （原始內容存檔於2022-03-23）.

[1]

[2]

[3]

[4]

[5]

[6]